Freshleaf Analytics News

FreshLeaf Analytics welcomes TGA interim decision on CBD down-scheduling September 9th 2020 Therapeutic Goods Administration (TGA) sticks to their guns on initial proposal for over-the-Counter

July SASB numbers spike as Australia shoots for a more open minded future By Nisha Karyn linkedin.com/in/nishasreenivasan The Therapeutic Goods Administration (TGA) reported 5564 approvals

TGA warns medical cannabis industry about advertising regulation breaches The Therapeutic Goods Administration (TGA), Australia’s health products regulator, has issued a stern warning to the

The Export Control Legislation Amendment (Certification of Narcotic Exports) Bill 2020, which passed the Senate on June 17, will allow the Commonwealth Department of Agriculture,

A CBD product might soon be available and subsidised on the Pharmaceutical Benefits Scheme   Families of children with severe drug-resistant epilepsy might soon be

NZ recreational cannabis bill released – prioritises social good over profits New Zealanders will go to the polls on September 19 to vote for their

Australian government proposes CBD be made available for retail sale Today the Therapeutic Goods Administration released the Department of Health-initiated proposal to make low-dose CBD

Australian Senate Committee tables recommendations from inquiry into barriers to medical cannabis The Community Affairs and References Committee tabled their report today (25/3/20) on the

What does a global recession mean for the cannabis industry? COVID-19 is wreaking havoc on the global economy. And there are genuine concerns about a

Medical cannabis quality crack-down   The Therapeutic Goods Administration (TGA) has announced it will be ramping up the number of quality audits it conducts on

We attended the ODC’s consultation session on proposed medical cannabis license changes so you didn’t have to The Office of Drug Control (ODC) held consultation